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Abstract 
Saccharomyces cerevisiae has been widely established as a platform microorganism for 
industrial production of fuels and chemicals from lignocellulosic biomass. However, we are still 
encountering several challenges to achieve cost-effective production of cellulosic biofuels, such 
as the sequential utilization of sugar mixtures caused by glucose repression and the low 
efficiency of synthesizing fatty acid derived advanced biofuels. 
 In this thesis, we aim to improve the production of advanced biofuels in S. cerevisiae 
using protein engineering and synthetic biology approaches. To overcome glucose repression, a 
cellobiose utilization pathway consisting of a cellodextrin transporter and a β-glucosidase was 
introduced into S. cerevisiae to allow co-fermentation of mixed sugars. However, the utilization 
of cellobiose was still much lower than that of glucose, and the uptake of cellobiose was 
considered the rate-limiting step for cellobiose fermentation. Therefore, directed evolution of the 
cellodextrin transporter (CDT2) was carried out to improve the uptake activity and thus 
cellobiose fermentation. After three rounds of directed evolution, both the specific activity and 
transporter expression level of CDT2 were increased, leading to 2.15 fold improvement of the 
cellobiose uptake activity. Using high cell density fermentation under anaerobic conditions, the 
best mutant conferred 2.67 fold and 4.96 fold increase in the cellobiose consumption rate and 
ethanol productivity, respectively.  
 Besides bioethanol, we are also interested in advanced biofuels that have similar 
properties to current transportation fuels. Since most of the advanced biofuels are derived from 
fatty acids, efficient production is limited by the low efficiency and high energy input of the fatty 
acid biosynthesis pathways. Reversal of β-oxidation cycles has been engineered to produce a 
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series of fatty acid derived fuels and chemicals in Escherichia coli. Thus, another goal of this 
thesis is to construct a new fatty acid biosynthesis platform based on the reversal of β-oxidation 
cycles for advanced biofuel production in S. cerevisiae. Using synthetic biology approaches, 
reversed β-oxidation pathways were constructed and characterized to be able to produce butanol, 
indicating the functional reversal of β-oxidation cycles. Future work will focus on expanding this 
platform to produce other fatty acid derived advanced biofuels such as biodiesel (fatty acid ethyl 
ester, FAEE).  
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Chapter 1 Introduction 
1.1 Cellulosic Biofuels 
Biological conversion of plant-derived lignocellulosic materials into biofuels has been 
intensively investigated as a result of increasing concerns on energy security, sustainability and 
global climate change (1). Saccharomyces cerevisiae, also known as baker’s yeast, which has 
been used for alcohol fermentation for thousands of years, is an excellent organism for cellulosic 
biofuel production, for its high tolerance to alcohols, well-studied genetic and physiological 
background, the availability of large number of genetic tools, and the compatibility of high-
density and large-scale fermentation (2). Unfortunately, wild type S. cerevisiae strains cannot 
utilize pentose sugars, especially xylose, the second most abundant carbohydrate component in 
lignocellulosic biomass. Heterologous xylose utilization pathways, including the bacterial 
isomerase pathway and the fungal oxo-reductive pathway, have been introduced to enable xylose 
metabolism (3). Although steady progress has been achieved to construct efficient xylose-
fermenting yeasts after intensive engineering work, the uptake and metabolism of xylose are still 
completely inhibited by glucose (4-6). One explanation for glucose repression (or catabolite 
repression) lies in the lack of xylose specific transporters in S. cerevisiae. Thus, xylose can only 
be transported via the hexose transporters, whose affinity for xylose is two orders of magnitude 
lower than that for glucose (7-9). This glucose repression phenomenon results in sequential 
utilization of glucose and xylose (Figure 1.1A), thus low yield and productivity of biofuels (4). 
Therefore, the construction of a yeast strain that can consume sugar mixtures efficiently and 
simultaneously is one of the biggest challenges for cost-effective production of cellulosic 
biofuels. 
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 Figure 1.1 Introduction of a cellodextrin transporter and an intracellular β-glucosidase allowing cellobiose/xylose 
co-fermentation. The traditional biofuel production scheme (A) suffers from sequential sugar utilization and low 
production efficiency, while the cellobiose fermentation strategy (B) allows simultaneous utilization of mixed sugars, 
thus higher biofuel production efficiency. Red, blue, green, and yellow color indicates cellobiose, glucose, pentose, 
and ethanol, respectively. 
 
 Recently, cellodextrin transporters were identified and characterized, and co-expression 
of a cellodextrin transporter and an intra-cellular β-glucosidase was proposed to be an efficient 
strategy to eliminate glucose repression in S. cerevisiae (10). In this system, cellobiose is 
transported by the cellodextrin transporter and hydrolyzed by β-glucosidase to release glucose 
intracellularly. Since the intracellularly released glucose is metabolized very fast, there will be 
no or very low glucose present in the medium, which liberates the hexose transporters for 
pentose uptake only. In other word, cellobiose and pentose can enter the cell via two separate 
transportation systems. As a result, glucose repression was eliminated and co-fermentation of 
cellobiose/xylose (5, 6) and cellobiose/galactose (11) were achieved in the engineered yeast 
strain (Figure 1.1B).  
 
 Currently, two cellodextrin transporters were characterized from Neurospora crassa: 
cellodextrin transporter 1 (CDT1) is a symporter with higher cellobiose uptake activity (Vmax), 
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while cellodextrin transporter 2 (CDT2) is a facilitator with much lower activity (10). Recent 
work on improving cellobiose fermentation performance mainly focused on CDT1 (5, 6, 11-16), 
because of the higher transporter activity and better cellobiose fermentation performance under 
aerobic or oxygen-limited conditions. However, CDT1 is not optimal for anaerobic fermentation, 
a preferred process for industrial applications, since energy (ATP) consumption is coupled to 
cellobiose uptake. On the contrary, the facilitator nature of CDT2 endows the energetic benefits 
under anaerobic conditions, due to no ATP consumption for cellobiose uptake. Therefore, CDT2 
has the potential to develop a better system for industrial production of cellulosic biofuels. 
 
1.2 Directed Evolution of Transporters 
Protein engineering, including the directed evolution approach, the knowledge-driven rational 
design approach, and a hybrid approach combining directed evolution and rational design, has 
been widely used to improve the performance of a wide variety of enzymes and pathways (17, 
18). Although directed evolution has been successfully used to improve the activity, specificity, 
and stability of industrially important enzymes (19-21), its utilization in membrane-bound 
protein engineering is only limited to a few applications, such as the light-transducing protein 
bacteriorhodopsin (22, 23), bacterial efflux pumps (24, 25), and xylose transporters in both 
Escherichia coli (26) and S. cerevisiae (27). The membrane-bound feature of these proteins 
significantly limits the power of protein engineering. Rational design is hindered by the lack or 
limited availability of high-resolution structural information. Due to the difficulties in expressing 
and crystalizing membrane proteins, there are only a few crystal structures available, especially 
for transporter proteins (28, 29). To date (as of May 31, 2013), there are only 1,271 membrane 
proteins with crystal structures (http://blanco.biomol.uci.edu/mpstruc/), whereas there are 91,359 
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structures deposited into the Protein Data Bank (http://www.rcsb.org/pdb/home/home.do). 
Directed evolution is limited by the difficulty in determining the activity of membrane proteins, 
let alone the development of a high-throughput screening system. As the bridge between intra- 
and extra-cellular environment, membrane proteins are mainly involved in the transduction of 
extracellular signals, transportation of substances through membrane, and generation of energy, 
whose activities are difficult or labor-intensive to determine (30, 31). Fortunately, sugar 
transporters, mediating the uptake of sugars into cells, are essential to initiate the cellular 
metabolism, and a high throughput screening method based on cell growth rate can be readily 
developed. Engineering of xylose transporters was carried out in a host with the xylose 
utilization pathway integrated to the chromosome and all hexose transporters inactivated (27). 
Due to the lack of an endogenous cellobiose uptake system in S. cerevisiae, it will be much 
easier and straightforward to develop a high throughput screening method, such as the colony 
size based screening strategy for cellodextrin transporter engineering. 
 
1.3 Fatty Acid Derived Advanced Biofuels 
Although ethanol is currently the leading biofuel molecule produced as the alternative 
transportation fuel, it has many shortcomings such as low energy density, high corrosivity, and 
hydroscopicity (32). Thus, there is an increasing effort to produce advanced biofuels or the so-
called “drop-in” biofuels that have similar properties to current transportation fuels.  Examples of 
advanced biofuels include butanol, fatty acid ethyl ester (FAEE), and alkane, all of which can be 
produced from either the natural or engineered fatty acid biosynthetic pathways (33).   
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Fatty acid biosynthesis (FAB) is catalyzed by the enzyme system called fatty acid 
synthase (FAS), which is rather conserved in nature. The classic FAB involves in the elongation 
of acyl-acyl carrier protein (ACP) precursors using malonyl-ACP as the extender unit (34). The 
generated long chain fatty acyl-ACPs can be converted to alkanes by introducing a heterologous 
pathway from cyanobacteria containing an acyl-ACP reductase (AAR) and an aldehyde 
deformylating oxygenase (ADO) (35). As for the production of biodiesels (FAEEs) and fatty 
alcohols (36, 37), fatty acyl-CoAs are the substrate, which can also be generated from fatty acyl-
ACPs. Free fatty acids are released from the ACP group by thioesterase (TE) and then activated 
to form fatty acyl-CoAs by fatty acyl-CoA synthase (FAA). The synthesis of FAEEs and fatty 
alcohols are catalyzed by wax synthase/diacylglycerol acyltransferase (WS/DGAT) and fatty 
acyl-CoA reductase (FAR), respectively (Figure 1.2).  
 
 
Figure 1.2 Overview of the production of fatty acid derived advanced biofuels. FAS, fatty acid synthase; AAR, 
acyl-ACP reductase; ADO, aldehyde deformylating oxygenase; TE, thioesterase; FAA, fatty acyl-CoA synthase; 
FAR, fatty acyl-CoA reductase; WS/DGAT, wax synthase/diacylglycerol acyltransferase. 
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Although the significance of FAB in advanced biofuels production, fatty acid does not 
accumulate to high levels naturally, due to the low flux and high regulation. Therefore, intensive 
metabolic engineering work has been carried out to re-direct the flux to FAB, such as the 
overexpression of thioesterase, fatty acyl-CoA synthase, acetyl-CoA carboxylase, and global 
transcription factors (38). Besides the classic FAB mechanisms shared by most of organisms, 
nature also evolved several special mechanisms to synthesize fatty acids de novo, such as the 
elongase system (39, 40) and fermentative pathway (41, 42). Although not widely distributed in 
nature, these special pathways possess significant advantages over the traditional ones, in terms 
of pathway efficiency and controllability of the fatty acid chain length. 
 
1.3.1 Traditional Type-I and Type-II FAS 
Based on the architecture, FAS can be divided into two classes, type-I FAS and type-II FAS, 
which are mainly present in eukaryotes and prokaryotes, respectively (43). The type-I FAS is 
characterized by being composed of large multifunctional polypeptides that carry all the proteins 
necessary for FAB on one or two large polypeptide chains. In the case of type-II system, mono-
functional proteins are discretely expressed from a series of separate genes. Type-II FAS is 
found mostly in bacteria, but also in eukaryotic organelles, such as mitochondria and plastids 
(34). In some actinomycetes, such as Mycobacterium species, both type-I and type-II FASs are 
present (44). 
 Although the organization of the FAS system varies between different organisms, the 
individual enzymatic reactions of FAB are essentially the same (34, 43). FAB begins with the 
conversion of acetyl-CoA into malonyl-CoA by acetyl-CoA carboxylase (ACC) at the cost of 
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ATP, which is then transferred to ACP by malonyl-CoA:ACP transacylase. The generated 
malonyl-ACP is used as an extender unit, condensing with acyl-ACP to form β-ketoacyl-ACP 
with two more carbon units. The extended β-ketoacyl-ACP is subject to an NADPH-dependent 
reduction to form β-hydroxyacyl-ACP, whose hydroxyl group is removed by β-hydroxyacyl-
ACP dehydratase, leading to the formation of trans-2-enoyl-ACP. The double bond is then 
reduced in another NADPH-dependent reaction by the trans-2-enoyl-ACP reductase. Each 
elongation cycle results in the synthesis of acyl-ACP with the fatty acyl chain extended by two 
carbon units. 
 
 
Figure 1.3 Overview of the traditional FAB mechanisms. The elongation cycle is repeated several times, until the 
generation of C16- or C18-ACP. 
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1.3.2 Elongase for de novo Fatty Acid Biosynthesis 
As mentioned above, the traditional FAS system utilizes malonyl-ACP as the extender unit and 
NADPH as the reducing force to elongate the acyl chain, highlighting the ATP, NADPH, and 
ACP dependence (34). A different de novo FAS system, the microsomal elongase, was described 
in Trypanosoma brucei, a eukaryotic human parasite that causes sleeping sickness (39, 40). 
Genome sequence indicates the presence of a putative Type-II FAS system, but experimental 
results suggest that Type-II FAS is not responsible for de novo fatty acid synthesis. 1) The 
components are membrane associated proteins, while soluble proteins are generally found for a 
Type-II FAS system. 2) Several traditional Type-II FAS inhibitors, such as triclosan and 
cerulenin, which inhibit trans-2-enoyl-ACP reductase and β-ketoacyl-ACP synthase (45), 
respectively, will not affect the bulk fatty acid synthesis. 3) RNA interference (RNAi) silencing 
of ACP, a key component of type II systems, has no effect on de novo FA synthesis as well. 
Later, the system was characterized to use three elongases instead of a type-II synthase (Figure 
1.4).  
 In this microsomal elongase system, malonyl-CoA serves as the extender unit and CoA is 
the acyl chain carrier. In other words, this system is ATP, NADPH, and CoA dependent. What’s 
more, trypanosomes have different fatty acid requirements during their life cycle, as they 
encounter various growth environments (39). It is found that the fatty acid requirement was 
achieved via the chain specificity of elongases, with Elo1 converting C4 to C10-CoA, Elo2 
extending C10 to C14-CoA, and Elo3 elongating C14 to C18-CoA (Figure 1.4). The modular 
property of the elongase system will allow the accessibility for chain length engineering. For 
example, if only Elo1 is included into the cyanobacterial alkane biosynthetic pathway, C7 and C9 
alkanes will be the major products, which are the same as gasoline.  
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Figure 1.4 Trypanosomal elongase system for de novo fatty acid biosynthesis. 
 
1.3.3 Fermentative Fatty Acid Biosynthesis in the Mitochondria of Euglena gracilis 
Another special mechanism for de novo FAB was described in the mitochondria of Euglena 
gracilis (41, 42). So far, five different FAS systems have been reported for E. gracilis, two type-
II FAS localized in the chloroplasts, one type-I FAS in the cytosol, one microsomal FAS, and 
one mitochondrial FAS. The mitochondrial system is involved in anaerobic wax ester 
fermentation. This fermentative system was featured to be malonyl-CoA (or ATP) independent, 
and have the ability to synthesize fatty acids directly from acetyl-CoA as both primer and 
extender.  In addition, NADH, instead of NADPH, serves as the reducing power (Figure 1.5). 
Due to the ATP and ACP independence and CoA and NADH dependence, the fermentative FAB 
proceeds by reversal of the β-oxidation cycles. Compared with the traditional FAB, the 
fermentative pathway is featured for its energetic benefits of ATP independence and availability 
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of CoA and NADH versus ACP and NADPH inside the cell. The advantages of such system was 
demonstrated by a recent report to reverse β-oxidation cycles to synthesize a series of chemicals 
and fuels at the highest titer ever reported (46, 47). Although genes coding the fermentative fatty 
acid synthesis pathway are not well characterized yet, the availability of its genome sequence 
will definitely help to decipher the genetic code and benefit in designing efficient fatty acid 
derived biofuel synthetic pathways.  
  
 
Figure 1.5 Fermentative fatty acid biosynthesis in the mitochondrion of Euglena gracilis. 
 
1.4 Project Overview 
This thesis focuses on improving advanced biofuels production in S. cerevisiae using protein 
engineering and synthetic biology approaches. One of the major challenges for economical 
biofuel production is to consume all sugar components efficiently and simultaneously, due to the 
widely distribution of glucose repression in nature. Although cellobiose fermentation has been 
set as an efficient system to achieve mix sugar co-fermentation, its utilization rate is still much 
lower than that of glucose. Thus, one aim of this thesis is to improve the efficiency of cellobiose 
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fermentation via directed evolution of the cellodextrin transporter, which is considered as rate-
limiting for cellobiose metabolism. Besides bioethanol, increasing effort in biofuel industry is 
devoted to producing advanced biofuels that have similar properties to current transportation 
fuels. Currently, efficient advanced biofuel production is limited by the low flux, high energy 
input, and complicated regulation of FAB. Thus, another aim of this thesis is to construct a new 
FAB platform for advanced biofuel production. Notably, aim 1 and aim 2 can be integrated to 
allow the production of advanced biofuels from cellulosic materials, which is the ultimate goal of 
bioenergy research. 
 Chapter 2 mainly focused on improving anaerobic cellobiose fermentation via directed 
evolution of the cellodextrin transporter. As mentioned, CDT1 is a symporter with higher 
cellobiose uptake activity (Vmax), while CDT2 is a facilitator with much lower activity. Although 
CDT2 has the potential to develop a better system for industrial production of cellulosic biofuels 
due to the energetic benefits of no ATP consumption for cellobiose uptake, cellobiose 
fermentation is limited by the low transporter activity. To overcome the main limitation of CDT2, 
we sought to increase its cellobiose uptake activity using a directed evolution strategy. 
 In Chapter 3 of this thesis, we attempted to reverse β-oxidation cycles in yeast for 
efficient production of advanced biofuels. Compared with the traditional FAB, which is ATP, 
ACP, and NADPH dependent, the reversed β-oxidation pathway is featured for its ATP and ACP 
independence and CoA and NADH dependence. The energetic benefits of ATP independence 
and availability of CoA and NADH versus ACP and NADPH confer advantages for efficient 
fatty acid biosynthesis. Recent reports to synthesize a series of chemicals and fuels were 
achieved by reversing β-oxidation cycles in Escherichia coli via systems biology and synthetic 
biology approaches. The advantages of such system was demonstrated by the highest reported 
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titers of fuels and chemicals produced. Taking the merits of yeast for biofuel production into 
account, we sought to develop a platform for advanced biofuel production based on the reversal 
of β-oxidation cycles via synthetic biology approaches in S. cerevisiae.  
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Chapter 2 Directed Evolution of a Cellodextrin Transporter for Improved 
Biofuel Production under Anaerobic Conditions in Saccharomyces cerevisiae 
2.1 Introduction 
Introduction of a cellobiose utilization pathway consisting of a cellodextrin transporter and a β-
glucosidase into Saccharomyces cerevisiae enables co-fermentation of cellobiose and xylose (1, 
2). Cellodextrin transporter 1 (CDT1) from Neurospora crassa has been established as an 
effective transporter for the engineered cellobiose utilization pathways (1-8). However, 
cellodextrin transporter 2 (CDT2) from the same species is a facilitator and has the potential to 
be more efficient than CDT1 under anaerobic conditions due to its energetic benefits (9). 
Currently, CDT2 has a very low activity and is considered rate-limiting in cellobiose 
fermentation. In this chapter, directed evolution of CDT2 was carried out to increase cellobiose 
uptake activity and anaerobic cellobiose fermentation performance.  
 First of all, a high throughput screening method based on colony size was developed to 
engineer the cellodextrin transporter. Owing to the important role of the sugar utilization 
pathway on cellular metabolism, the activity of the fermenting pathway can be coupled to the 
growth rate on a specific sugar, such as cellobiose and xylose. Therefore, the enrichment or 
adaptive evolution methods were commonly used to engineer efficient sugar fermenting strains 
(10). Despite the success in constructing efficient cellobiose (4, 5) or xylose (11-13) fermenting 
yeasts, the improved phenotypes are often found to be related to the modification of the host 
genome rather than the engineered pathway, and it is rather difficult to figure out the molecular 
mechanisms of the random modifications. To minimize the impact of host adaptation, a colony 
size based screening method was developed in our group to engineer efficient sugar utilization 
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pathways (6, 8). Sugar uptake is the first step of cellular metabolism, and it is generally assumed 
that transporter is rate-limiting in the whole fermentation pathway (4, 7, 14, 15). Therefore, the 
colony size based screening method was also applied to engineer the cellobiose transporter.  
 Using the developed high throughput screening method, three rounds of directed 
evolution of CDT2 was carried out, and the cellobiose uptake activity of CDT2 was increased by 
2.15 fold, which resulted from both increased specific activity and transporter expression level. 
Under anaerobic conditions with high cell density, the evolved mutant conferred significantly 
improved cellobiose fermentation performance, with the sugar consumption rate and ethanol 
productivity increased by 2.67 fold and 4.96 fold, respectively.  
 
2.2 Results 
2.2.1 Construction of Cellobiose Utilization Pathways 
The yeast homologous recombination based DNA assembler method (16) was used to construct 
recombinant plasmids and a library of CDT2 mutants. Oligonucleotides used and strains and 
plasmids constructed are listed in Appendix and Table 2.1, respectively.  
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Table 2.1 Strains and plasmids constructed in this study. 
Name Description 
Strains  
INVSc1 MATa/MATα his3Δ1/his3Δ1 leu2/leu2 trp1-289/trp1-289 ura3-52/ura3-52 
DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK–, 
mK+) phoA supE44 λ– thi-1 gyrA96 relA1 
Plasmids  
pRS415 Single copy plasmid in S. cerevisiae with LEU2 marker 
pRS425-801 Plasmid with the TEF1p-NCU00801-PGK1t cassette 
pRS425-809 Plasmid with the TEF1p-NCU00809-PGK1t cassette 
pRS425-8114 Plasmid with the TEF1p-NCU08114-PGK1t cassette 
CDT-Eng-H pRS415-PYK1p-NCU00130-ADH1t-TEF1p-PstI-PGK1t 
CDT1-BGL NCU00801(CDT1) inserted into CDT-Eng-H 
NCU00809-BGL NCU00809 inserted into CDT-Eng-H 
CDT2-BGL (WT) NCU08114 (CDT2) inserted into CDT-Eng-H 
QFN CDT2(Q207H/F209I/N311H) inserted into CDT-Eng-H 
Q CDT2(Q207H) inserted into CDT-Eng-H 
F CDT2(F209I) inserted into CDT-Eng-H 
N CDT2(N311H) inserted into CDT-Eng-H 
QF CDT2(Q207H/F209I) inserted into CDT-Eng-H 
QN CDT2(Q207H/N311H) inserted into CDT-Eng-H 
FN CDT2(F209I/N311H) inserted into CDT-Eng-H 
QNI CDT2(Q207H/N311H/I505T) inserted into CDT-Eng-H 
WT-eGFP CDT2-eGFP inserted into CDT-Eng-H 
QFN-eGFP CDT2(Q207H/F209I/N311H)-eGFP inserted into CDT-Eng-H 
QN-eGFP CDT2(Q207H/N311H)-eGFP inserted into CDT-Eng-H 
QNI-eGFP CDT2(Q207H/N311H/I505T)-eGFP inserted into CDT-Eng-H 
  
 To facilitate the construction of cellobiose utilization pathways, a helper plasmid with the 
functional elements PYK1p-NCU00130-ADH1t-TEF1p-PstI-PGK1t cloned into pRS415 was 
constructed, named CDT-Eng-H hereafter (Figure 2.1). NCU00130 is a N. crassa gene encoding 
β-glucosidase and expressed intra-cellularly in S. cerevisiae. The helper plasmid was linearized 
by PstI digestion to allow the insertion of cellodextrin transporters. NCU00801, NCU00809, and 
NCU08114 were cloned from pRS425-801, pRS425-809, and pRS425-8114 constructed in our 
previous studies (2), respectively, using primers oJL0099 and oJL0100.  
18 
 
  
 
Figure 2.1 Vector map of the helper plasmid for CDT2 engineering, CDT-Eng-H. NCU00130 is the β-glucosidase 
from N. crassa, and the cellobiose utilization pathways are constructed by inserting cellodextrin transporters into the 
PstI site, which was flanked by TEF1 promoter and PGK1 terminator.  
 
2.2.2 Development of a Colony Size Based Screening Method for CDT Engineering 
A colony size based screening method was developed previously to engineer efficient sugar 
utilization pathways (6, 8), which was also applied to engineer the cellodextrin transporter. 
Before performing directed evolution, this method was characterized using three N. crassa 
cellodextrin transporters with different activities, including NCU00801 (CDT1), NCU00809, and 
NCU08114 (CDT2) (9). In accordance with the previous work (1, 2), CDT1 performed the best 
in cellobiose fermentation, followed by CDT2 and then NCU00809, under aerobic conditions. 
After spreading onto a cellobiose plate, the colony size was correlated with the growth rate in 
liquid medium, and therefore the cellobiose uptake activity (Figure 2.2). These results also 
confirmed that CDT2 was rate-limiting in cellobiose fermentation under the screening conditions.  
CDT-Eng-H
9899 bp
APr LEU2
NCU00130
PYK1p
TEF1p
CEN-ori
F1 ORI
PMB1
ADH1t
PGK1t
PstI (6696)
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Figure 2.2 Development of a colony size based screening method for CDT engineering. Different CDTs were 
introduced into CDT-Eng-H, a plasmid containing the β-glucosidase (BGL) from N. crassa. The colony size on 
cellobiose agar plate (middle panel) was confirmed to be positively related to the growth rate in liquid culture (left 
panel), as well as the cellobiose uptake activity (right panel). Bars on the right panel represented the relative 
cellobiose uptake activity (9), with CDT1 activity set to 100%. 
 
2.2.3 CDT2 Engineering via Directed Evolution 
Using the colony size based screening method, a general protocol for CDT2 engineering was 
developed (Figure 2.3). Error-prone PCR (17) was used to create a library of CDT2 mutants, 
which was then cloned into linearized CDT-Eng-H. The concentration of MnCl2 was adjusted to 
keep the mutation rate around 3 bp per kb (4-5 bp per gene). After heat shock, a small amount of 
the transformant culture (0.1%) was spread onto an SCD-Leu plate to determine the library size. 
Under optimal conditions, 500 ng for each DNA fragment, a library ranging from 10
5
 to 10
6
 
transformants could be obtained. The rest of the transformants were diluted appropriately, and 
around 10
4
 transformants were spread onto SCC-Leu agar plates. After incubation at 30°C for 3 
days, many large colonies appeared and the top 60 colonies were picked and pre-cultured in 
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SCD-Leu medium. After growth to saturation, cells were inoculated into 3 mL YPC liquid 
medium in culture tubes and samples were taken at 24h, 28h, and 32h after inoculation to 
determine the cell density and specific growth rate. The top 12 mutants with either the highest 
cell density or specific growth rate were selected and the plasmids were extracted and re-
transformed into fresh yeast cells to eliminate host adaptation. After re-transformation, the 
selected mutants were further confirmed using flask fermentation under oxygen limited 
conditions (10 mL YPC medium in 50 mL un-baffled flask) and samples were taken at 24h, 28h, 
32h, and 36h after inoculation to measure cell density, cellobiose consumption, and ethanol 
productivity. The top 3 mutants with the highest cellobiose consumption and ethanol production 
rates were selected for final characterization under anaerobic conditions. The anaerobic tube was 
filled with 10 mL YPC medium and samples were taken every day until all sugar was consumed. 
In the whole process of library screening, seed cultures were grown in 3 mL SCD-Leu medium 
under aerobic conditions for 36 hours in 14 mL culture tubes, and inoculated into YPC at an 
initial OD600 of 0.05. Iterative rounds of directed evolution were carried out until no further 
improvement was observed. 
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Figure 2.3 A general scheme to engineer sugar transporters, using the colony size based screening method.  
 
 For easier operation and based on the assumption that oxygen level cannot significantly 
change the activity of a facilitator, the initial screening steps were carried out under aerobic or 
oxygen-limited conditions, and only the final step of confirmation was performed under 
anaerobic conditions. In the first round of directed evolution, the top 2 mutants were found to 
carry the same mutations, Q207H/F209I/N311H (QFN), which validated the developed protocol 
for cellobiose transporter engineering. The role of these mutations in cellobiose fermentation was 
analyzed by creating all different combinations of the mutations including Q207H (Q), F209I (F), 
N311H (N), Q207H/F209I (QF), Q207H/N311H (QN), and F209I/N311H (FN). As shown in 
Figure 2.4, variants QN, QFN, N, and Q grew faster than the wild-type CDT2 (WT), while 
variants QF and F grew slower than WT. Accordingly, it can be concluded that Q207H and 
N311H are beneficial mutations, whereas the F209I mutation impairs the cellobiose uptake 
activity.  
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Figure 2.4 Characterization of the role of Q207H/F209I/N311H (QFN) mutations in cellobiose fermentation 
performance by creating all possible combinations, including Q207H (Q), F209I (F), N311H (N), Q207H/F209I 
(QF), Q207H/N311H (QN), and F209I/N311H (FN).   
 
 Using the mutants obtained in the second round of directed evolution, the cellobiose 
fermentation performance was compared under aerobic, oxygen-limited, and anaerobic 
conditions. In agreement with our assumption that the activity of a facilitator is not significantly 
changed by the oxygen level, the growth and cellobiose consumption rates of these mutants were 
closely correlated under different conditions (Figure 2.5).  
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Figure 2.5 Correlation of cellobiose fermentation performance under oxygen-limited and anaerobic conditions. 
Growth curve (A, C) and cellobiose consumption profile (B, D) were determined under both oxygen-limited (A, B) 
and anaerobic conditions (C, D). 
 
 After validating our developed protocol for CDT engineering, a third round of directed 
evolution was carried out using the best mutant, QN, as the template. Similarly, mutants with 
increased cellobiose consumption rate were obtained, and DNA sequencing revealed that the best 
mutant harbored only one additional mutation, I505T, named QNI hereafter. The fourth round of 
directed evolution did not result in mutants with significantly improved cellobiose fermentation 
performance (data not shown), thus further rounds of directed evolution of CDT2 was not 
continued.  
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2.2.4 Cellobiose Fermentation Performance of the Evolved CDT2 Mutants 
The cellobiose fermentation performance (sugar consumption rate, ethanol productivity and yield) 
of WT and the best mutants obtained in the first (QFN), second (QN), and third (QNI) round of 
directed evolution was compared under anaerobic conditions. Using the same conditions as 
library screening, the specific growth rate, sugar consumption rate, and ethanol productivity were 
increased by 2.15 fold, 2.65 fold, and 4.69 fold, respectively (Figure 2.6).  
 
Figure 2.6 Cellobiose fermentation profiles of CDT2 mutants obtained in the first
 
(QFN), second (QN), and third 
(QNI) round of directed evolution. The specific growth rate (A), cellobiose consumption rate (B), and ethanol 
productivity (C) of these transporters were compared using the library screening conditions. Ethanol used to 
solubilize anaerobic growth factors (0.5-1 g/L) was subtracted before calculating ethanol productivity and ethanol 
yield. To determine the specific growth rate, cellobiose consumption rate and ethanol productivity, data points 
within linear range were included for analysis. Final data points were used to determine ethanol yield. 
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 If a high cell density was used for anaerobic fermentation, the strain containing the 
evolved transporter was able to consume 20 g/L cellobiose in less than 9 hours, while the wild-
type transporter required more than 30 hours to use up the same amount of cellobiose. The best 
mutant (QNI) conferred an increase of 2.67 fold and 4.96 fold for the cellobiose consumption 
rate and ethanol productivity, respectively (Figure 2.7). Moreover, the overall ethanol yield, 
which is another important parameter for cost-effective production of cellulosic biofuels, was 
improved by more than 25%. 
 
 
Figure 2.7 Cellobiose fermentation profiles of CDT2 mutants obtained in the first
 
(QFN), second (QN), and third 
(QNI) round of directed evolution. The cellobiose consumption rate (A) and ethanol productivity (B) of these 
transporters were compared using high cell density fermentation under anaerobic conditions. Ethanol produced by 
CDT2 mutants represented the total ethanol in the fermentation broth subtracted by ethanol used to solubilize the 
anaerobic growth factors (0.5-1 g/L). 
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2.2.5 Characterization of the Evolved CDT2 Mutants  
To investigate the role of mutations on cellobiose fermentation and cellobiose uptake activity, we 
first determined the relative expression levels of CDT2 and its mutants. To fuse enhanced green 
fluorescent protein (eGFP) at the C-terminus of the cellodextrin transporters with a Gly-Ser-Gly-
Ser linker in between, primers oJL0099 and oJL0154 were used to amplify the CDT2 fragment 
and oJL0155 and oJL0100 to amplify the eGFP fragment, respectively, which were then cloned 
into the linearized CDT-Eng-H using the DNA assembler method. As shown in Figure 2.8A, the 
cytoplasmic membrane localization of the transporter-eGFP fusion proteins was confirmed by 
confocal microscope imaging. Therefore, the relative expression levels of the cellodextrin 
transporters could be quantified by their fluorescence intensity. Under cellobiose fermentation 
conditions, the expression levels of WT, QFN, and QN were similar, while the expression level 
of QNI was about 18% higher (Figure 2.8B).  
 
 
Figure 2.8 Cytoplasmic membrane localization of the CDT2-eGFP fusion protein and relative expression levels of 
cellodextrin transporters quantified by eGFP relative fluorescence unit (RFU). A) Confocal microscope image of 
yeast cells expression WT-eGFP cultured in cellobiose medium. B) Relative expression levels of cellodextrin 
transporters in both glucose medium and cellobiose medium. NC is the control strain (WT) without eGFP tagging. 
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 To further correlate the sugar uptake activity and the cellobiose fermentation 
performance, the cellobiose uptake activity of WT, QFN, QN, and QNI was determined by the 
oil stop method. As expected, the cellobiose uptake activity was correlated with the fermentation 
performance, i.e. higher activity resulted in increased specific growth rate, cellobiose 
consumption rate, and ethanol productivity (Figure 2.9A). By normalizing the transporter activity 
to the relative protein expression level, it was found that the specific activity of QN and QNI 
were nearly the same, indicating that Q207H and N311H increased the specific uptake activity, 
while I505T contributed to increased transporter expression level (Figure 2.9B). Notably, the 
absolute value of cellobiose uptake activity (WT) was higher than that reported (9), which could 
be caused by the difference in culture conditions. In the previous work, the strain was pre-
cultured in glucose medium, while cellobiose medium was used in the present study. As a 
selection pressure, cellobiose could lead to higher transporter expression level, as shown in 
Figure 2.8B. It was also found that cellodextrin transporters suffered from degradation when 
glucose was used as the carbon source (personal communication with Prof. Yong-Su Jin). 
Therefore, the enhanced expression level and increased protein stability might explain the higher 
cellobiose uptake activity observed in the current study. 
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Figure 2.9 Cellobiose uptake activity of CDT2 mutants. Sugar uptake assay was performed using [
3
H]-Cellobiose 
and normalized to either cellular level (A) or protein level (B). For the transporter activity at cellular level, 
cellobiose uptake assay was performed at OD600 1. Cellobiose uptake activity at the protein level (B) was normalized 
to the relative transporter expression level, which was quantified by fluorescence intensity (the specific cellobiose 
uptake activity of WT-eGFP was set to 1). 
 
2.3 Discussion 
Intensive research has been focused on producing fuels and chemicals from lignocellulose 
biomass (18, 19). To make the cellulosic biofuel fermentation process economically feasible, the 
host should be able to consume a mixture of sugars efficiently and simultaneously. However, the 
presence of glucose repression significantly impairs the efficiency and productivity, which is 
considered as one of the major obstacles for cost-effective production of cellulosic biofuels. 
Three general strategies are proposed to overcome glucose repression to allow co-fermentation 
of mixed sugars (20): the construction of glucose-derepressed yeasts by perturbing the glucose 
sensing and signaling network, the introduction and engineering of xylose specific transporters, 
and the introduction of a cellobiose utilization pathway including a cellodextrin transporter and a 
β-glucosidase. Due to the complexity of the regulatory system, yeast strains without glucose 
repression on xylose metabolism have never been obtained, even after intensive systematic 
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metabolic engineering (20, 21). As for xylose transporters, they suffer from either low uptake 
activity or low specificity (14, 22), and it is assumed that xylose specific transporters with high 
uptake activity may not exist in nature (15, 20). Although directed evolution was carried out on 
xylose transporters, efficient co-fermentation of glucose and xylose has not been achieved either 
(15). On the contrary, the last strategy has been proven to be an efficient strategy to overcome 
glucose repression, enabling co-fermentation of cellobiose/xylose (1, 2) and cellobiose/galactose 
(3) efficiently. Another advantage of the cellobiose pathway is the application in consolidated 
bioprocessing (simultaneous saccharification and fermentation, SSF), because the utilization of 
cellobiose instead of glucose can eliminate the requirement of β-glucosidase supplementation in 
current cellulase cocktails (9).  
 Although there are numerous protein engineering examples (23-25), there are only a few 
examples of engineering membrane proteins, especially transporters (15, 26-28). As the bridge 
between intra- and extra-cellular environments, membrane proteins are mainly involved in the 
transduction of extra-cellular signals, transportation of substances through membrane, and 
generation of energy, whose activities are difficult or labor-intensive to determine (29, 30). Thus, 
directed evolution is limited by the difficulty in determining the activity of membrane proteins, 
let alone the development of a high-throughput screening system. Fortunately, sugar transporters 
are essential to initiate the cellular metabolism, and a high throughput screening method based 
on cell growth rate can be readily developed (Figure 2.2 and Figure 2.3). Using this high-
throughput screening system, cellobiose fermentation performance (Figure 2.6) and cellobiose 
uptake activity (Figure 2.7) were significantly improved after three rounds of directed evolution. 
Due to the lack of 3-D structure of cellodextrin transporters, the HMMTOP online tool (31) and 
the TMRPres2D tool (32) were used to predict and visualize the secondary structure of CDT2. 
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Based on the predicted topology, Q207 and N311 were located in the sixth and seventh 
transmembrane helixes, while I505 was located in the last intra-cellular loop (Figure 2.10). The 
predicted positions of these mutations were consistent with their corresponding roles: the inner 
membrane located residues might be involved in the cellobiose channel formation and affect the 
specific uptake activity, while the residue in the intra-cellular loop might not be related to 
cellobiose uptake directly. Previous work on transporter engineering also revealed that the 
mutation in the intra-cellular loops could increase the sugar uptake activity (7, 15), which might 
result from increased transporter expression levels. 
 
 
Figure 2.10 Sequence-structure mapping of CDT2 mutations. The topology of CDT2 on cellular membrane was 
predicted by HMMTOP online program. The ovals indicate the mutations obtained in the first two rounds of 
directed evolution, while the star represents the third round mutation. 
 
 Recently, a bacterial cellobiose phosphorylase together with a highly functional CDT1 
mutant were introduced into S. cerevisiae and confirmed to perform better than the hydrolytic 
pathway under low oxygen or acetate supplemented conditions (4). The energy requirement of 
CDT1 for cellobiose uptake could be to some extent compensated by the phosphorolytic pathway 
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under stress conditions, owing to the energetic benefits of cellobiose phosphorolysis. In the 
hydrolytic pathway, cellobiose is cleaved by β-glucosidase to generate two glucose molecules, 
which need to be phosphorylated by 2 ATP molecules (per cellobiose) to enter glycolysis. In the 
phosphorolytic pathway, cellobiose is cleaved by phosphorylase to release one glucose molecule 
and one glucose-1-phophate molecule, and only one ATP molecule (per cellobiose) is consumed 
to initiate fermentation (33). Despite the energetic benefits, a CDT1 mutant with significantly 
improved uptake activity was necessary to provide a “push” driving force to enable efficient 
cellobiose fermentation (4). Therefore, a cellobiose pathway combining the engineered CDT2 
with cellobiose phosphorylase may have the maximized energetic benefits, and further improve 
cellobiose fermentation performance under anaerobic conditions. 
 
2.4 Conclusions 
In summary, the cellobiose uptake activity of CDT2 was increased via directed evolution to 
improve anaerobic cellobiose fermentation performance, including the specific growth rate, 
cellobiose consumption rate, ethanol productivity, and ethanol yield. For the best mutant (QNI) 
obtained after three rounds of directed evolution, the two mutations located in transmembrane 
helixes conferred a 1.75 fold increase in the specific cellobiose uptake activity, while the 
mutation in the intra-cellular loop was determined to increase the transporter expression level 
rather than the specific activity. To our knowledge, this is the first report of using directed 
evolution to increase the activity of a cellodextrin transporter and the productivity of cellulosic 
biofuels under anaerobic conditions. 
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2.5 Materials and Methods 
2.5.1. Strains,  Media, and Cultivation Conditions 
E. coli strain DH5α (Life Technologies, Grand Island, NY) was used to maintain and amplify 
plasmids. S. cerevisiae INVSc1 strain (Life Technologies) was used as the host for homologous 
recombination based cloning and cellobiose fermentation. Yeast strains were cultivated in 
complex medium consisting of 2% peptone and 1% yeast extract supplemented with either 2% 
glucose (YPD) or 2% cellobiose (YPC).  Recombinant strains were grown on synthetic complete 
medium consisting of 0.17% yeast nitrogen base, 0.5% ammonium sulfate, and 0.07% amino 
acid drop out mix without leucine (CSM-Leu, MP Biomedicals, Solon, OH), supplemented with 
2% glucose (SCD-Leu) or 2% cellobiose (SCC-Leu). E. coli strains were cultured at 37
o
C in 
Luria-Bertani broth containing 100 μg/mL ampicillin. S. cerevisiae strains were cultured at 30oC 
and 250 rpm for aerobic growth, and 30
o
C and 100 rpm in un-baffled shaker flasks for oxygen 
limited fermentation. For anaerobic fermentation, anaerobic culture tubes with butyl rubber 
stoppers and aluminum seals (Chemglass Life Sciences, Vineland, NJ) were vacuumed and 
purged with nitrogen to remove the residual oxygen and 480 mg/L Tween-80 and 10 mg/L 
ergosterol were supplemented as anaerobic growth factors (34). Tween-80 and ergosterol were 
dissolved in ethanol, and the supplementation resulted in around 0.5-1 g/L ethanol in the 
fermentation broth. Go Taq DNA polymerase for error-prone PCR was purchased from Promega 
(Madison, WI). All restriction enzymes, Q5 High Fidelity DNA polymerase, and the E. coli - S. 
cerevisiae shuttle vector, pRS415, were purchased from New England Biolabs (Ipswich, MA). 
All chemicals were purchased from either Sigma-Aldrich or Fisher Scientific. 
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2.5.2 DNA Manipulation 
The yeast homologous recombination based DNA assembler method (16) was used to construct 
recombinant plasmids and a library of CDT2 mutants. Briefly, Polymerase chain reaction (PCR) 
was used to generate DNA fragments with homology arms at both ends, which were purified 
with a QIAquick Gel Extraction Kit (Qiagen, Valencia, CA) and co-transformed along with the 
linearized backbone into S. cerevisiae. To confirm the correct clones, yeast plasmids were 
isolated using a Zymoprep Yeast Plasmid Miniprep II Kit (Zymo Research, Irvine, CA) and re-
transformed into E. coli DH5α competent cells. Plasmids were isolated using a QIAprep Spin 
Miniprep Kit (Qiagen) and confirmed using both diagnostic PCR and DNA sequencing. Yeast 
strains were transformed using the LiAc/SS carrier DNA/PEG (35) method, and transformants 
were selected on SCD-Leu plates. 
 
2.5.3 High Cell Density Fermentation 
A single colony from the newly transformed plate was inoculated into 3 mL SCD-Leu medium, 
and cultured under aerobic conditions for 36 h. Then 1 mL seed culture was used to inoculate 15 
mL YPC medium in a shake flask and cultured for an additional 24 h. The late-log phase cells 
were harvested and washed twice in double distilled water (ddH2O), and inoculated into 10 mL 
YPC medium at an initial OD600 of 10 in a 20 mL anaerobic culture tube. Cellobiose 
fermentation was performed under anaerobic conditions and samples were taken every 3-4h after 
inoculation until all cellobiose was consumed. 
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2.5.4 [
3
H]-Cellobiose Uptake Assay 
Cellobiose transport assay was performed using the oil-stop method as described previously (9). 
A single colony of a yeast strain expressing a cellodextrin transporter fused to eGFP was pre-
grown in SCD-Leu medium for around 36 h, which was then inoculated into 10 mL fresh YPC 
medium. Mid-log phase cells cultured under oxygen-limited conditions were harvested and 
washed 3 times with the assay buffer (30 mM MES-NaOH and 50 mM ethanol, pH5.5), and 
resuspended to an OD600 of 20. The uptake assay was initiated by adding 50 μL cells into 50 μL 
[
3
H]-cellobiose (Moravek Biochemicals, Brea, CA) layered over 100 μL silicone oil. To stop the 
reaction, cells were centrifuged for 1 min at 15000 rpm to achieve phase separation, with the 
cells at the bottom, silicon oil in the middle, and celllobiose solution at the top. Then the tubes 
were frozen in ethanol/dry ice and the bottom fraction with cell pellets was collected and 
solubilized in 1 mL NaOH (0.5 M) overnight. Half of the supernatant was transferred into a 
scintillation vial and 3 mL ScintiSafe* Econo 1 Cocktail (Fisher Scientific) was added to read 
counts per minute (CPM) by a Beckman LS6500 scintillation counter (Beckman Coulter, Brea, 
CA). The maximum uptake rate (Vmax) was determined by measuring the linear rate of cellobiose 
uptake at the concentration of 400 μM, which is about 100 fold higher than the Km of CDT2. The 
value of Vmax was normalized to both cellular level (cell density) and protein level (protein 
expression level as quantified by the eGFP fluorescence intensity). 
 
2.5.5 Confocal Microscope Imaging  
Yeast cells expressing eGFP tagged cellodextrin transporters were cultured in either glucose or 
cellobiose medium. A small droplet of mid-log phase cells were transferred onto a pierce of 
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cover glass and the fluorescence images were taken using a Zeiss LSM 700 Confocal 
Microscope (Carl Zeiss Microscopy, Thornwood, NY). 
 
2.5.6 Analytical Methods 
Cell growth was determined by measuring the absorbance at 600 nm using a Biotek Synergy 2 
Multi-Mode Microplate Reader (Winooski, VT), and eGFP fluorescence intensity was measured 
using a Tecan  Safire
2
 microplate reader (San Jose, CA) at 488±5 nm and 509±5 nm wavelengths 
for excitation and emission, respectively. Extra-cellular metabolites, including cellobiose, 
glucose, acetate, glycerol, and ethanol, were detected and quantified using Shimadzu HPLC 
(Columbia, MD) equipped with an Aminex HPX-87H column (Bio-Rad, Hercules, CA) and 
Shimadzu RID-10A refractive index detector. The column was kept at 65
o
C and 0.5 mM sulfuric 
acid solution was used as a mobile phase at a constant flow rate of 0.6 mL/min. Each data point 
represents the mean of at least duplicates. 
 
2.5.7 Prediction of Transporter Topology on Cellular Membrane  
The topology of CDT2 on the cellular membrane was predicted using the HMMTOP online tool 
(http://www.enzim.hu/hmmtop/) (31), and the predicted result was visualized by the 
TMRPres2D tool (http://bioinformatics.biol.uoa.gr/TMRPres2D/) (32).  
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Chapter 3 Reversal of the β-Oxidation Cycles in Saccharomyces cerevisiae for 
the Production of Advanced Biofuels 
3.1 Introduction 
After decades of intensive research, commercial production of bioethanol has been achieved (1). 
Due to its intrinsic shortcomings such as low energy density, high corrosivity, and 
hydroscopicity, ethanol is not compatible with existing fuel distribution infrastructure (2).  Thus, 
increasing effort has been devoted to produce advanced biofuels, such as butanol, long chain 
alcohols, fatty acid ethyl esters, and alkanes, which have similar properties to current 
transportation fuels. Notably, most of the “drop-in” fuels are derived from fatty acids (fatty acyl-
CoAs or fatty acyl-ACPs), which can be produced by the endogenous fatty acid biosynthetic 
(FAB) pathways (3). However, the traditional FAB systems suffer from high energy input and 
complicated regulation, which significantly hinders efficient and cost-effective production of 
advanced biofuels. Generally, the classic FASs require the consumption of ATP to activate 
acetyl-CoA to malonyl-CoA and use ACP and NADPH as the co-factors (4, 5). Interestingly, 
fatty acid degradation pathway or the β-oxidation pathway, which happens in the opposite 
direction as that of FAB, proceeds in a much more efficient manner. For example, no ATP 
consuming reaction was involved and CoA and NADH was used instead of ACP and NADPH as 
the co-factors (6, 7).   
 To overcome the major limitation of FASs, a recent report demonstrated that the fatty 
acid degradation enzymes were functional in both degradative and synthetic directions and the E. 
coli β-oxidation cycles could be functionally reversed to synthesize a series of advanced fuels 
and chemicals, including short, medium, and long chain alcohols and fatty acids (8, 9). 
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Compared with the traditional engineering strategy, there were several advantages of this novel 
platform for advanced biofuel production, such as high efficiency by bypassing the energy 
consuming and rate-limiting step to produce malonyl-CoA and flexibility to engineer the 
production of fatty alcohols and fatty acids with different chain length. 
 
 
Figure 3.1 Overview of advanced biofuel synthesis by reversing the β-oxidation cycles. ①  β-Ketoacyl-CoA 
Synthase (KS); ② β-Ketoacyl-CoA Reductase (KR); ③ β-Hydroxyacyl-CoA Dehydratase (HTD); ④ Trans-2-
Enoyl-CoA Reductase (TER); ⑤Fatty Acyl-CoA Reductase (FAR); ⑥  Alcohol Dehydrogenase (ADH); ⑦ 
Thioesterase (TE); ⑧ Aldehyde Decarbonylase; ⑨ Wax Synthase/Diacylglycerol Acyltransferase (WS/DGAT) 
 
 Compared with E. coli, the currently most popular host for metabolic engineering and 
synthetic biology studies, S. cerevisiae is a more suitable for industrial-scale production of 
biofuels from lignocellulosic biomass, because of its high tolerance to harsh conditions, the 
ability of high density fermentation, and free of phage contamination (1, 10). Although the 
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reversal of β-oxidation for efficient fuel synthesis was demonstrated in E. coli, it might be 
extended to this eukaryotic system as well, owing to the ubiquitous nature of β-oxidation (7, 8). 
Therefore, we aimed to develop a new platform, based on the reversed β-oxidation pathways, to 
synthesize efficiently and cost-effectively a series of fuels and chemicals in S. cerevisiae, 
including but not limited to fatty acids, fatty alcohols, FAEEs, alkanes, and even waxes (Figure 
3.1). As proof of concept, β-oxidation enzymes were cloned from various species and expressed 
in S. cerevisiae to test the production of butanol, which requires the reversal of only one cycle of 
β-oxidation. If possible, more metabolic engineering and synthetic biology efforts will be put to 
extend this platform to produce long chain fatty acid derived advanced biofuels and redirect the 
flux towards the desired products.  
 
3.2 Results 
3.2.1 Construction of Helper Plasmids to Facilitate Gene Cloning and Pathway Assembly 
To facilitate gene cloning and pathway assembly, six helper plasmids with the whole promoter or 
terminator as the homology region between two adjacent cassettes were constructed. As shown 
in Figure 3.2 and Table 3.1, besides the eGFP cassette (promoter-eGFP-terminator), there was an 
additional promoter sequence at the 3’ end of the terminator in each helper plasmid, serving as 
the homologous region for pathway assembly. Each eGFP sequence was flanked by a unique 
BamHI site at 5’ end and XhoI site at 3’ end, which allowed the cloning of desired genes by 
replacing the eGFP sequence. In addition, unique restriction enzyme sites were also introduced 
to flank at both ends of each cassette, which conferred the flexibility to remove the whole 
cassette by restriction digestion. 
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Table 3.1 Helper plasmids constructed for the reversed β-oxidation pathways 
Plasmids Construct 
Helper1 pRS425-StuI-GPM1p-BamHI-eGFP-XhoI-ADH1t-AvrII 
Helper2 pRS425-AvrII-ADH1t-GPDp-BamHI-eGFP-XhoI-CYC1t-SbfI-ENO2p 
Helper3 pRS425-SbfI-ENO2p-BamHI-eGFP-XhoI-PGK1t-NotI-TPI1p 
Helper4 pRS425-NotI-TPI1p-BamHI-eGFP-XhoI-TPI1t-SacII-TEFK1p 
Helper5 pRS425-SacII-TEF1p-BamHI-eGFP-XhoI-TEF1t-XmaI 
Helper6 pRS425-TEF1t-PGK1p-BamHI-eGFP-HindIII-HXT7t 
 
 As shown in Figure 3.2, the whole cassettes together with the downstream homologous 
sequences were PCR amplified and co-transformed into S. cerevisiae to assemble the whole 
pathway via the DNA assembler method. 
 
 
Figure 3.2 Schemes of gene cloning and pathway construction via DNA assembler using the six helper plasmids. 
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3.2.2 Searching for Functional β-Oxidation Enzymes Expressed in the Cytosol of S. cerevisiae 
To test the possibility of the reversal of β-oxidation cycle in S. cerevisiae, more than 40 genes 
from various species were cloned to construct the reversed β-oxidation pathways. Using the E. 
coli pathway as the start point, gene candidates to be cloned followed the following criteria: 1) E. 
coli and yeast β-oxidation enzymes (6, 7, 11, 12); 2) proteins sharing high homology with the E. 
coli reversed β-oxidation pathway (8); 3) putative enzymes that are predictive to have the desired 
functions. Due to the availability of the CoA substrates, enzyme activity assays were carried out 
using C4-CoAs, including acetoacetyl-CoA, β-hydroxybutyryl-CoA, and crotonoyl-CoA (trans-
2-Butenoyl-CoA). Considering the broad specificity of the β-oxidation enzymes, the performed 
enzyme assays using C4-CoAs should be sufficient to represent the β-oxidation activities (13). 
Since β-oxidation enzymes were localized either in the mitochondrion or the peroxisome in 
eukaryotes, the targeting sequences were predicted using the on-line tools and removed during 
cloning in order to be expressed in the cytosol of S. cerevisiae. 
 
3.2.2.1 β-Ketoacyl-CoA Synthase (KS)  
The β-ketoacyl-CoA synthase activity was carried out in the thiolysis direction using acetoacetyl-
CoA as the substrate. As shown in Table 3.2, several KS candidate genes were cloned from both 
S. cerevisiae and E. coli. The thiolase from Clostridium acetobutylicum (CaThl), which is 
involved in the fermentative production of butanol (14), was used as the positive control. Both 
acetyl-transferase (ERG10, EcAtoB and EcYqeF) and acyl-transferase (cytoFOX3 and EcFadA) 
were included for analysis, which showed short chain specificity (15) and broad specificity (12), 
respectively. 
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Table 3.2 β-Ketoacyl-CoA synthases cloned for the reversed β-oxidation pathways 
KS Activity Comments 
Helper1-CaThl Positive Control Specific for short chain acyl-CoAs 
Helper1-ERG10 Functional  
Helper1-cytoFox3 Functional Broad specificity 
Helper1-EcAtoB No activity  
Helper1-EcYqeF No activity  
Helper1-EcFadA No Activity  
 
 As shown in Figure 3.3, ERG10 showed the highest activity towards acetoacetyl-CoA 
among all enzymes tested, which was consistent with a previous report that ERG10 was optimal 
for butanol production in yeast (16). Unfortunately, all the enzymes cloned from E. coli are un-
functional. By removing the peroxisomal targeting sequences, FOX3 was relocalized to the 
cytosol and functionally expressed. Although the activity of cytoFOX3 was a bit lower than that 
of ERG10, this β-oxidation enzyme should show broad specificity towards different chain length 
substrates. Therefore, cytoFOX3 was chosen to construct the reversed β-oxidation pathways. 
 
 
Figure 3.3 KS activity assay using acetoacetyl-CoA as the substrate. 
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3.2.2.2 Multi-functional Enzyme (KR and HTD) 
The second and third steps of β-oxidation were carried out by a multi-functional enzyme, FOX2 
in S. cerevisiae (12) and FadB in E. coli (11). Unfortunately, neither of them could be 
functionally expressed in the cytosol of S. cerevisiae. Therefore, more FOX2 homologs were 
found by BLAST search and cloned for enzyme activity assay, as listed in Table 3.3. 
Table 3.3 Multi-functional enzymes cloned for the reversed β-oxidation pathways. All strains 
used are all requested from ARS culture collection (NRRL). H8, H10, H15, and H22 failed to be 
cloned or the strains requested failed to grow 
Plasmid Constructs Origin 
cytoFOX2 Helper2-cytoFOX2 Saccharomyces cerevisiae 
EcFadB Helper2-EcFadB Escherichia coli 
H1 Helper2-cytoFOX2 Torulaspora delbrueckii 
H2 Helper2-cytoFOX2 Candida glabrata  
H3 Helper2-cytoFOX2 Naumovozyma dairenensis  
H4 Helper2-cytoFOX2 Vanderwaltozyma polyspora  
H5 Helper2-cytoFOX2 Naumovozyma castellii  
H6 Helper2-cytoFOX2 Kluyveromyces lactis  
H7 Helper2-cytoFOX2 Tetrapisispora phaffii  
H8 Helper2-cytoFOX2 Lachancea thermotolerans  
H9 Helper2-cytoFOX2 Zygosaccharomyces rouxii  
H10 Helper2-cytoFOX2 Eremothecium cymbalariae  
H11 Helper2-cytoFOX2 Ashbya gossypii  
H12 Helper2-cytoFOX2 Pichia pastoris  
H13 Helper2-cytoFOX2 Pichia farinosa  
H14 Helper2-cytoFOX2 Hansenula polymorpha  
H15 Helper2-cytoFOX2 Debaryomyces hansenii  
H16 Helper2-cytoFOX2 Candida parapsilosis 
H17 Helper2-cytoFOX2 Pichia guilliermondii  
H18 Helper2-cytoFOX2 Candida dubliniensis  
H19 Helper2-cytoFOX2 Candida tropicalis 
H20 Helper2-cytoFOX2 Scheffersomyces stipitis  
H21 Helper2-cytoFOX2 Lodderomyces elongisporus  
H22 Helper2-cytoFOX2 Spathaspora passalidarum  
H23 Helper2-cytoFOX2 Candida tenuis  
H24 Helper2-cytoFOX2 Yarrowia lipolytica 
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 Unfortunately, as shown in Table 3.4, although more than 20 candidate enzymes from 
different species were tested, none was found to possess KR and HTD activities towards 
acetoacetyl-CoA and crotonoyl-CoA.  
 
 
 
Figure 3.4 HBD and CRT activity assay of the multifunctional enzymes. 
47 
 
 There were several explanations for the lack of KR and HTD activities of FOX2 
homologs towards acetoacetyl-CoA and crotonoyl-CoA. FOX2 from S. cerevisiae was found to 
have the highest activity towards medium chain and long chain substrates, while the activity 
towards C4 compound could be much lower (17). Another explanation could be the different 
folding environments between cytosol and peroxisome, which might completely abolish their 
enzymatic activities. To test the possibility of the first hypothesis, FOX2 from Yarrowia 
lipolytica was also included in this study. As oleaginous yeasts can accumulate fatty acids and 
lipids to high levels (18), it is rational to speculate that they also have a very efficient β-oxidation 
system. Unfortunately, the Yarrowia FOX2 was found to have no enzymatic activity either 
(Figure 3.4). Therefore, it was concluded that the difference in folding environments between 
cytosol and peroxisome caused more than 20 FOX2 homologs to be un-functionally expressed in 
the cytosol of S. cerevisiae.  
Table 3.4 KRs and HTDs cloned from Yarrowia lipolytica 
Plasmids Constructs Comments 
CaHbd Helper2-CaHbd Positive control, specific for short chain substrate 
Yl01 Helper2-YALI0A02046  
Yl02 Helper2-YALI0C08811 Active KR, broad specificity 
Yl03 Helper2-YALI0F29975  
CbCrt Helper6-CbCrt Positive control, specific for short chain substrate 
Yl06 Helper6-YALI0B10406 Active HTD, broad specificity 
Yl07 Helper6-YALI0F22121  
Yl08 Helper6-YALI0D06215  
Yl09 Helper6-YALI0A07733  
Yl10 Helper6-YALI0F28567  
Yl11 Helper6-YALI0D09493  
 
 Different from S. cerevisiae, some oleaginous yeasts were found to have another set of β-
oxidation system in the mitochondrion (19), besides the traditional system in the peroxisome. 
Therefore, the mitochondrial β-oxidation enzymes together with some homologs sharing high 
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homology were cloned from Y. lipolytica, and the β-hydroxybutyryl-CoA dehydrogenase from C. 
acetobutylium (CaHbd) and crotonase from C. beijerinckii (CbCrt) were included as the positive 
controls (14, 20) (Table 3.4). Different from the peroxisomal β-oxidation system that a 
multifunctional enzyme can catalyze the second and third step of β-oxidation, there are two 
separate enzymes in the mitochondrial system to possess KR and HTD activities, encoded by 
YALI0C08811 and YALI0B10406, respectively (19). As shown in Figure 3.4, both of the 
mitochondrial β-oxidation enzymes could be functionally expressed in the cytosol of yeast, both 
of which showed comparable enzymatic activities with the Clostridium equivalents. Thus, these 
two enzymes were chosen to construct the reversed β-oxidation pathways. 
 
3.2.2.3 Trans-2-Enoyl-CoA Reductase (TER) 
The first step of β-oxidation was carried out by fatty acid oxidase with the involvement of 
oxygen molecule, which was the only irreversible step (6, 7, 12). Thus, trans-2-Enoyl-CoA 
reductases (TERs), which are involved in fatty acid biosynthesis (FAB) and only catalyze the 
reaction in the reducing direction, were chosen to construct the reversed β-oxidation pathways 
instead of the fatty acid oxidase. In fact, several TERs, such as those from Euglena gracilis 
(EgTer) and Treponema denticola (TdTer), have been characterized (21-23) and determined to 
significantly improve the production of butanol (24, 25) and short chain fatty acids (9) in E. coli. 
Therefore, TERs from E. coli, S. cerevisiae, E. gracilis and T. denticola and some homologs that 
shared high homology were cloned (Table 3.4). 
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Table 3.5 TERs cloned for the reversed β-oxidation pathways 
Plasmids Comments 
Helper3-cytoETR1 Active, involved in the mitochondrial FAB in S. cerevisiae 
Helper3-ZTA1  
Helper3-cytoSPS19  
Helper3-YNL134C  
Helper3-YLR460C  
Helper3-YCR102C  
Helper3-EcYdiO  
Helper3-EcFabI Active, involved in FAB in E. coli 
Helper3-EgTer Active, involved in the mitochondrial FAB in Euglena gracilis 
Helper3-TdTer Active, involved in FAB in Treponema denticola 
  
 As shown in Figure 3.5, several candidates involved in the biosynthesis of fatty acids, 
such as the endogenous ETR1, FabI from E. coli, TER from E. gracilis, and TER from T. 
denticola, were determined to possess the TER activity. Consistent with the previous work (21, 
22), TdTer was found to have the highest activity when crotonoyl-CoA was used as the substrate. 
Therefore, ETR1 and TdTer were chosen to construct the reversed β-oxidation pathways. 
 
 
Figure 3.5 TER activity assay using crotonoyl-CoA as the substrate. 
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3.2.3 Butanol Biosynthesis as Proof-of-concept 
After intensive cloning and enzyme activity assays, several candidates were found to be 
functionally expressed in yeast with the desired activities, with at least one functional enzyme in 
each step of β-oxidation. Therefore, using the DNA assembler method (26), reversed β-oxidation 
pathways could be readily constructed. As a proof of concept, butanol biosynthesis that requires 
only one cycle reversal of β-oxidation was selected. As shown Table 3.6, butanol pathways 
based on reversed β-oxidation were constructed using ERG10/cytoFOX3-cytoYl02-cytoYl06-
TdTer/cytoETR1, based on the enzyme activity assay results. To pull butyryl-CoA to synthesize 
butanol, the CoA-acylating aldehyde dehydrogenase from E. coli (EcEutE) (27, 28) and butanol 
dehydrogenase from C. acetobutylium (CaBdhB) (14) were included in the reversed β-oxidation 
pathways. 
Table 3.6 Reversed β-oxidation pathways constructed for the synthesis of butanol 
Pathways Constructs 
BuPa31 pRS426-ERG10-cytoYl02-cytoYl06-TdTer-EcEutE-CaBdhB 
BuPa32 pRS426-cytoFOX3-cytoYl02-cytoYl06-TdTer-EcEutE-CaBdhB 
BuPa34 pRS426-ERG10-cytoYl02-cytoYl06-cytoETR1-EcEutE-CaBdhB 
BuPa35 pRS426-cytoFOX3-cytoYl02-cytoYl06-cytoETR1-EcEutE-CaBdhB 
BuPa37 pRS426-ERG10-eGFP-cytoYl06-TdTer-EcEutE-CaBdhB 
BuPa38 pRS426-cytoFOX3-eGFP-cytoYl06-TdTer-EcEutE-CaBdhB 
 
 
 As shown in Figure 3.6, butanol, although at very low titer, could be detected using the 
strains containing the constructed reversed β-oxidation pathways, including BuPa31, BuPa32 
BuPa34, and BuPa35. Currently, BuPa34 produced the highest amount of butanol, with a titer of 
as high as 20 mg/L in the wild-type yeast strain. Although the butanol titer was still rather low 
compared with that in Clostridia (20) and E. coli (8, 24, 25), it was approximately 10 fold higher 
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than a previous report using the Clostridum butanol fermentative pathway in yeast (16). This 
result indicated the high efficiency of the reversed β-oxidation pathways. 
 
 
Figure 3.6 Production of butanol by the reversed β-oxidation pathway. 
 
 The assembled pathways containing functional β-oxidation enzymes could produce a 
small amount of butanol, indicating the reversal of β-oxidation cycles. To be 100% sure that the 
detected butanol was produced via the reversed β-oxidation pathway, pathway deletion and 
complementation were carried out. Replacing cytoYl02 having KR activity with eGFP, no 
butanol production was observed, while co-expression of cytoYl02 together with the “deletion 
pathways” (BuPa37 and BuPa38) could restore the butanol production (Figure 3.7). 
 
 
Figure 3.7 Complementation of butanol production by the reversed β-oxidation pathway. 
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3.3 Discussion 
The reversal of β-oxidation was confirmed by butanol production and the next step is to develop 
this pathway into a platform for synthesis of a wide variety of fatty acid-derived fuels and 
chemicals. The yeast β-oxidation enzymes show broad specificity towards short-, medium-, and 
long-chain substrates (6, 7), which promises a versatile platform but also challenges the control 
of the chain length of the final products. Currently, the chain length of the products was mainly 
controlled by the specificity of the terminal enzymes. If necessary, protein engineering will be 
carried out to engineer the terminal enzymes with desired properties. An alternative method to 
control the chain length of the major products is to use the animal β-oxidation system. Different 
from the case in yeast and fungi, fatty acids are degraded to medium chain acyl-CoA (C6-C10) in 
the peroxisome and then completely degraded into acetyl-CoA in the mitochondria (29). 
Therefore, by reversal of the animal mitochondria β-oxidation cycle, fuels and chemicals with 
medium chain length will be the major products. 
 Since S. cerevisiae is a natural host to produce ethanol and fatty acyl-CoA is produced by 
the reversed pathway, overexpression of additional one single protein, WS/DGAT, is sufficient 
to synthesize FAEE in the engineered yeast strain (Figure 3.1) (30). On the contrary, the product 
of the traditional FAB pathway is acyl-ACP, which should be thiolysed to release free fatty acid 
by thioesterase (TE) and then converted to acyl-CoA by fatty acyl-CoA synthase (FAA) (31). 
Therefore, besides the high efficiency of the reversed β-oxidation pathway, another advantage of 
such system is the decreased biosynthetic steps for FAEE production. 
 The high efficiency of the reversed β-oxidation pathway was characterized by its 
energetic benefits of the malonyl-CoA independence and the use of CoA and NADH instead of 
ACP and NADPH as the cofactors (8). However, compared with the high efficiency of the 
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reversed β-oxidation pathway in E. coli, this system seemed to not work very well in yeast, as 
shown by the relative low butanol productivity. One explanation for this discrepancy is the 
difference in acetyl-CoA biosynthesis. In E. coli, acetyl-CoA is steadily synthesized from 
pyruvate by either pyruvate dehydrogenase (PDH) under aerobic conditions (32) and pyruvate-
formate lyase (PFL) under anaerobic conditions (33). While in S. cerevisiae, acetyl-CoA is 
mainly generated in the mitochondria, and the reversed β-oxidation pathway enzymes are 
localized in the cytosol. What’s worse, S. cerevisiae lacks the machinery to export the 
mitochondrial acetyl-CoA to the cytosol (34). Thus, there is not enough substrate for the reversed 
β-oxidation pathway, due to the compartmentalization of acetyl-CoA metabolism. In S. 
cerevisiae, the cytosolic acetyl-CoA is generated via the PDH-bypass pathway, from pyruvate to 
acetaldehyde and then to acetate, which is activated to acetyl-CoA by the acetyl-CoA synthase 
(ACS) at the cost of two ATP molecules (35). The activation of acetate is the rate-limiting step in 
cytosolic acetyl-CoA synthesis, resulting from the low activity of ACS and high energy input. 
Several metabolic engineering strategies have been carried out to boost the availability of acetyl-
CoA in yeast, such as the use of an ACS mutant which showed much higher activity (36-39) and 
the introduction of heterologous acetyl-CoA biosynthetic pathways with less energy input (40, 
41). Notably, these strategies have been applied to improve the production of isoprenoids (36), 
polyhydroxybutyrate (38, 40), butanol (39), fatty acids (41), and α-santalene (37) in S. cerevisiae. 
Therefore, the construction of an acetyl-CoA overproducing yeast may significantly enhance the 
efficiency of the reversed β-oxidation pathway for advanced biofuel synthesis. 
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3.4 Conclusions and Future Plans 
To construct a functional reversed β-oxidation pathway, approximately 50 enzyme homologs 
were cloned from various species. Based on the enzyme activity assays, at least one functional 
enzyme was obtained for each catalytic step. To demonstrate the proof of concept, butanol 
biosynthesis that requires only one cycle reversal of β-oxidation was selected. The production of 
a small amount of butanol indicated a functionally reversed β-oxidation pathway. Future work 
will focus on metabolic engineering strategies to increase the intracellular acetyl-CoA level to 
further increase the titer and productivity of butanol and expand this platform to synthesize 
advanced fuel molecules with longer carbon chains.   
 
3.5 Materials and Methods 
3.5.1. Strains, Media, and Cultivation Conditions 
E. coli strain DH5α (Cell Media Facility, University of Illinois at Urbana Champaign) was used 
to maintain and amplify plasmids. S. cerevisiae CEN.PK2-1C (MATa ura3-52 trp1-289 leu2-
3,112 his3Δ1 MAL2-8C SUC2, EUROSCARF) was used as the host for homologous 
recombination based cloning and butanol fermentation. Yeast strains were cultivated in complex 
medium consisting of 2% peptone and 1% yeast extract supplemented with either 2% glucose 
(YPD).  Recombinant strains were grown on synthetic complete medium consisting of 0.17% 
yeast nitrogen base, 0.5% ammonium sulfate, and 0.07% amino acid drop out mix without 
leucine or uracil (MP Biomedicals, Solon, OH), supplemented with 2% glucose (SCD-Leu or 
SCD-Ura). E. coli strains were cultured at 37
o
C in Luria-Bertani broth containing 100 μg/mL 
ampicillin. S. cerevisiae strains were cultured at 30
o
C and 250 rpm for aerobic growth, and 30
o
C 
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and 100 rpm in un-baffled shaker flasks for oxygen limited fermentation. All restriction enzymes, 
Q5 High Fidelity DNA polymerase, and the E. coli - S. cerevisiae shuttle vectors, including 
pRS425 and pRS426, were purchased from New England Biolabs (Ipswich, MA). All chemicals 
were purchased from either Sigma-Aldrich or Fisher Scientific. 
 
3.5.2 DNA Manipulation 
The yeast homologous recombination based DNA assembler method (26) was used to construct 
the helper plasmids, clone candidate genes and assemble the reversed β-oxidation pathways. 
Briefly, polymerase chain reaction (PCR) was used to generate DNA fragments with homology 
arms at both ends, which were purified with a QIAquick Gel Extraction Kit (Qiagen, Valencia, 
CA) and co-transformed along with the linearized backbone into S. cerevisiae. All genetic 
elements, including promoters, coding sequences, and terminators, were PCR-amplified from 
their corresponding genomic DNAs. Wizard Genomic DNA Purification Kit (Promega, Madison, 
WI) was used to extract the genomic DNAs from both bacteria and yeasts, according to the 
manufacturer’s protocol. To confirm the correct clones, yeast plasmids were isolated using a 
Zymoprep Yeast Plasmid Miniprep II Kit (Zymo Research, Irvine, CA) and re-transformed into 
E. coli DH5α competent cells. Plasmids were isolated using a QIAprep Spin Miniprep Kit 
(Qiagen) and confirmed using both diagnostic PCRs and restriction digestions. Yeast strains 
were transformed using the LiAc/SS carrier DNA/PEG (42) method, and transformants were 
selected on either SCD-Leu or SCD-Ura plates. 
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3.5.3 Enzyme Activity Assays 
To measure the activity of enzymes expressed in yeast, a single colony was inoculated into 5 mL 
of SCD-Leu medium, and cultured under aerobic conditions for about 36 h. Then cells were 
collected by centrifugation at 4,000 g for 5 min at 4
o
C, washed twice with pre-chilled water, and 
resuspended in 250 μL Yeast Protein Extraction Reagent (YPER). After incubation at 25oC with 
700 rpm shaking in a thermomixer for 20 minutes, the supernatant containing all soluble proteins 
were separated by centrifugation at 14,000g for 10 min at 4
o
C and ready for enzyme activity 
assays. All the assays were performed in 96-well microplates at 30
o
C and the spectrophotometric 
changes were monitored using the Biotek Synergy 2 Multi-Mode Microplate Reader (Winooski, 
VT). The reaction was initiated by the addition of 20-40 μL cell extract, to a total volume of 200 
μL. Enzyme activity was calculated using the initial reaction rate and normalized to the total 
protein concentration determined by the Bradford assay. 
 The KS activity was measured by monitoring the disappearance of acetoacetyl-CoA, 
corresponding to the thiolysis direction of the enzymatic reaction, which was monitored by the 
decrease in absorbance at 303 nm. The reaction mixture contained 100 mM Tris-HCl (pH 8.0), 
10 mM MgSO4, 200 μM acetoacetyl-CoA, and 200 μM CoA.  
 The KR activity was measured by monitoring the decrease of absorption at 340 nm, 
corresponding to consumption of NADH in the reducing direction of the reaction. The reaction 
mixture contained 100 mM potassium phosphate buffer (pH 7.3), 200 μM NADH, and 200 μM 
acetoacetyl-CoA.  
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 The HTD activity was measured by the decrease of absorption at 263nm, corresponding 
to disruption of the carbon-carbon double bond of crotonoyl-CoA. The assay mixture contained 
100 mM Tris-HCl (pH 7.6) and 100 μM crotonoyl-CoA.  
 The TER activity was measured at 340 nm, corresponding to consumption of NADH to 
reduce crotonoyl-CoA. The reaction mixture contained 100 mM potassium phosphate buffer (pH 
6.2), 200 μM NADH, and 200 μM crotonoyl-CoA.  
 
3.5.4 Butanol Fermentation and Detection 
A single colony with the reversed β-oxidation pathway from the newly transformed plate was 
inoculated into 3 mL SCD-Ura medium, and cultured under aerobic conditions for 36 h. Then 
200 μL seed culture was transferred into 10 mL fresh SCD-Ura medium in a 50 mL unbaffled 
shaker flask at an initial OD600 of about 0.05, and cultured under oxygen-limited conditions for 
butanol fermentation. Samples were taken every 12 h after inoculation until no further increase 
in butanol production was observed. 
 Samples were centrifuged at 14,000 rpm for 10 min and the resulting supernatant was 
analyzed by a Shimadzu GCMS-QP2010 Plus GC-MS equipped with an AOC-20i+s 
autosampler and a DB-Wax column with a 0.25 μm film thickness, 0.25 mm diameter, and 30 m 
length (Agilent Inc., Palo Alto, CA). Injection port and interface temperature was set at 250 ºC, 
and the ion source set to 230 ºC. The helium carrier gas was set at a constant flow rate of 2 
mL/min. The oven temperature program was set as the following: a) 3 min isothermal heating at 
50ºC, b) increase at the rate of 15ºC min
-1
 to 120ºC, c) increase at the rate of 50ºC min
-1
 to 230ºC, 
d) and then isothermal heating at 230ºC for additional 2.5 min. The mass spectrometer was 
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operated with a solvent cut time of 1.5 min, an event time of 0.2 s, a scan speed of 2500 from the 
range of 30-500 mass to charge (m/z) ratio. Concentrations were determined by the standard 
curve methods, with 50 mg/L methanol as the internal standard. 
 
3.5.5 Prediction of the Mitochondrial and Peroxisomal Targeting Sequences  
The mitochondrial targeting sequences of the candidate proteins were predicted using the 
MITOPROT online tool (http://ihg.gsf.de/ihg/mitoprot.html) (43). The peroxisomal targeting 
sequences were predicted using the PTSs predictor from PeroxisomeDB 2.0 
(http://www.peroxisomedb.org/Target_signal.php) (44).  
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Appendix List of Primers used in this thesis. 
Primer  Sequence (5'-->3') Application 
oJL0099 gtttcatttttcttgttctattacaac Clone CDTs 
oJL0100 ctattattttagcgtaaaggatgggg 
oJL0101 atgtcgtctcacggctcccatgacggggcc CDTs confirmation 
oJL0102 ctaagcaacgatagcttcggacacatggcc 
oJL0103 atggctcacagcataaacgaaaaggaggcc 
oJL0104 ctaaattgtaactttctcgtcatccggcgc 
oJL0105 atgggcatcttcaacaagaagcccgtggct 
oJL0106 tcaagcaacagacttgccctcatgctcgtg 
oJL0141 attagaaagaaagcatagcaatctaatctaagttttaattacaaaatgggcatcttcaac CDT2 engineering  
oJL0142 gagaaaagaaaaaaattgatctatcgatttcaattcaattcaattcaagcaacagacttg 
oJL0144 caaggcgggaatgcgccatgaccag Construct point 
mutations of CDT2 
(WT, Q, F, N, QF, 
QN, FN, and QFN) 
oJL0146 gatgatggcgttgccggaccattgg 
oJL0147 tcaacaacgactggtcatggcgcattcccgccttgctccatgctttcccctccatcattc 
oJL0149 aacgactggtcatggcgcattcccgccttgctccaggctatcccctccatcattcagctc 
oJL0151 gtgggttcccgagtctccccgtttc 
oJL0154 gaacagctcctcgcccttgctcaccatactaccactaccagcaacagacttgccctcatg Construct CDT2-
eGFP oJL0155 attcacgagcatgagggcaagtctgttgctggtagtggtagtatggtgagcaagggcgag 
oJL0201 gcgcgcgtaatacgactcactatagggcgaattgaggcctcatgcgactgggtgagcata Construction of 
Helper1 (pRS425-
GPM1p-eGFP-
ADH1t-PYK1p) 
oJL0202 ccccggtgaacagctcctcgcccttgctcaccatggatcctttgattgatttgactgtgt 
oJL0203 cctcacgcaaaataacacagtcaaatcaatcaaaggatccatggtgagcaagggcgagga 
oJL0204 cttgaccaaacctctggcgaagaagtccaaagctctcgagttacttgtacagctcgtcca 
oJL0205 gatcactctcggcatggacgagctgtacaagtaactcgagagctttggacttcttcgcca 
oJL0206 ttgtactgagattaatctccaaaatagtagcattcctaggcatgccggtagaggtgtggt 
oJL0207 ggtcgctcttattgaccacacctctaccggcatgcctaggaatgctactattttggagat 
oJL0208 caagcgcgcaattaaccctcactaaagggaacaaaagctgtgtgatgatgttttatttgt 
oJL0437 agcgcgcgtaatacgactcactatagggcgaattgaggccttagtcgtgcaatgtatgac 
oJL0438 ccccggtgaacagctcctcgcccttgctcaccatggatcctattgtaatatgtgtgtttg 
oJL0209 gcgcgcgtaatacgactcactatagggcgaattgcctaggaatgctactattttggagat Construction of 
Helper2 (pRS425-
ADH1t-GPDp-
eGFP-CYC1t-
ENO2p) 
oJL0210 ccccggtgaacagctcctcgcccttgctcaccatggatcctgtgatgatgttttatttgt 
oJL0211 agacaccaatcaaaacaaataaaacatcatcacaggatccatggtgagcaagggcgagga 
oJL0212 gtgaatgtaagcgtgacataactaattacatgatctcgagttacttgtacagctcgtcca 
oJL0213 gatcactctcggcatggacgagctgtacaagtaactcgagatcatgtaattagttatgtc 
oJL0214 aagaaccctttctatacccgcagcgtcgacaccctgcagggcaaattaaagccttcgagc 
oJL0215 aggttttgggacgctcgaaggctttaatttgccctgcagggtgtcgacgctgcgggtata 
oJL0216 caagcgcgcaattaaccctcactaaagggaacaaaagctgtattattgtatgttatagta 
oJL0361 gcgcgcgtaatacgactcactatagggcgaattgcctagg agctttggacttcttcgcca 
oJL0362 ccccggtgaacagctcctcgcccttgctcaccatggatccatccgtcgaaactaagttct 
oJL0217 gcgcgtaatacgactcactatagggcgaattgcctgcagggtgtcgacgctgcgggtata Construction of 
Helper3 (pRS425-
ENO2p-eGFP-
PGK1t-TPI1p) 
oJL0218 ccccggtgaacagctcctcgcccttgctcaccatggatcctattattgtatgttatagta 
oJL0219 caccaagcaactaatactataacatacaataataggatccatggtgagcaagggcgagga 
oJL0220 aaaaattgatctatcgatttcaattcaattcaatctcgagttacttgtacagctcgtcca 
oJL0221 gatcactctcggcatggacgagctgtacaagtaactcgagattgaattgaattgaaatcg 
oJL0222 tcttccaccaacctgatgggttcctagatatagcggccgccaggaagaatacactatact 
oJL0223 ctctttagatccagtatagtgtattcttcctggcggccgctatatctaggaacccatcag 
oJL0224 caagcgcgcaattaaccctcactaaagggaacaaaagctgttttagtttatgtatgtgtt 
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oJL0225 gcgcgtaatacgactcactatagggcgaattggcggccgctatatctaggaacccatcag Construction of 
Helper4 (pRS425-
TPI1p-eGFP-
TPI1t-TEF1p) 
oJL0226 ccccggtgaacagctcctcgcccttgctcaccatggatccttttagtttatgtatgtgtt 
oJL0227 ctataactacaaaaaacacatacataaactaaaaggatccatggtgagcaagggcgagga 
oJL0228 aagaagataatatttttatataattatattaatcctcgagttacttgtacagctcgtcca 
oJL0229 gatcactctcggcatggacgagctgtacaagtaactcgaggattaatataattatataaa 
oJL0230 gagtaaaaaaggagtagaaacattttgaagctatccgcggtatataacagttgaaatttg 
oJL0231 aagatgttcttatccaaatttcaactgttatataccgcggatagcttcaaaatgtttcta 
oJL0232 caagcgcgcaattaaccctcactaaagggaacaaaagctgtttgtaattaaaacttagat 
oJL0233 gcgcgcgtaatacgactcactatagggcgaattgccgcggatagcttcaaaatgtttcta Construction of 
Helper5 (pRS425-
TEF1p-eGFP-
TEF1t) 
oJL0234 ccccggtgaacagctcctcgcccttgctcaccatggatcctttgtaattaaaacttagat 
oJL0235 agcatagcaatctaatctaagttttaattacaaaggatccatggtgagcaagggcgagga 
oJL0236 aagatatgcaactagaaaagtcttatcaatctccctcgagttacttgtacagctcgtcca 
oJL0237 gatcactctcggcatggacgagctgtacaagtaactcgagggagattgataagacttttc 
oJL0238 cgcaattaaccctcactaaagggaacaaaagctgcccgggatagcgccgatcaaagtatt 
oJL0421 cagtgagcgcgcgtaatacgactcactatagggcgaattgggagattgataagacttttc Construct Helper6 
(pRS425-TEF1t-
PGK1p-eGFP-
Hxt7t) 
oJL0422 ttagagcgtgatcatgaattaataaaagtgttcgcaaaggatcctgttttatatttgttg 
oJL0423 attatctactttttacaacaaatataaaacaggatcctttgcgaacacttttattaattc 
oJL0424 taggcaccccaggctttacactttatgcttccggctcctatgttgtgtggaattgtgagc 
oJL0671 aagtaattatctactttttacaacaaatataaaacaggatccatggtgagcaagggcgag 
oJL0672 ttaataaaagtgttcgcaaaaagcttttacttgtacagctcgtccatgccgagagtgatc 
oJL0475 ggttgagtgttgttccagtttggaacaagagtc Amply Helper1 
Cassette oJL0478 catgccggtagaggtgtggtcaataagag 
oJL0481 agctttggacttcttcgccagaggtttg Amply Helper2 
Cassette oJL0482 gcttggtgccacttgtcacatacaattc 
oJL0483 cctgcagggtgtcgacgctgcgggtatagaaag Amply Helper3 
Cassette oJL0484 gtatgtgttttttgtagttatagatttaagcaag 
oJL0487 gcggccgctatatctaggaacccatcaggttg Amply Helper4 
Cassette oJL0488 gattgctatgctttctttctaatgagcaagaag 
oJL0489 ccgcggatagcttcaaaatgtttctactc Amply Helper5 
Cassette oJL0490 gcgccgatcaaagtatttgttacgacaatatc 
oJL0491 ggagattgataagacttttctagttgc Amply Helper6 
Cassette oJL0492 gggtttcgccacctctgacttgagcgtc 
oJL0239 tcataacctcacgcaaaataacacagtcaaatcaatcaaa atgtctcagaacgtttacat Clone THL & KS 
homologues into 
Helper1 
oJL0240 tggagacttgaccaaacctctggcgaagaagtccaaagcttcatatcttttcaatgacaa 
oJL0241 tcataacctcacgcaaaataacacagtcaaatcaatcaaa atgggtaagggtgaatcgaa 
oJL0242 tggagacttgaccaaacctctggcgaagaagtccaaagctctattctttaataaagatgg 
oJL0243 tcataacctcacgcaaaataacacagtcaaatcaatcaaa atgaaaaattgtgtcatcgt 
oJL0244 tggagacttgaccaaacctctggcgaagaagtccaaagctttaattcaaccgttcaatca 
oJL0245 tcataacctcacgcaaaataacacagtcaaatcaatcaaa atgaaagacgttgtgattgt 
oJL0246 tggagacttgaccaaacctctggcgaagaagtccaaagctctattcgtcacgttcaatgg 
oJL0247 tcataacctcacgcaaaataacacagtcaaatcaatcaaa atggaacaggttgtcattgt 
oJL0248 tggagacttgaccaaacctctggcgaagaagtccaaagctttaaacccgctcaaacaccg 
oJL0363 ttttttagttttaaaacaccagaacttagtttcgacggat atgcctggaaatttatcctt Clone FOX2 
(KR+HTD) 
homologues from 
different yeast 
species into 
Helper2 
oJL0250 ggcgtgaatgtaagcgtgacataactaattacatgatttagttatccaatacaatgacgt 
oJL0365 ttttttagttttaaaacaccagaacttagtttcgacggat atgctttacaaaggcgacac 
oJL0252 gagggcgtgaatgtaagcgtgacataactaattacatgatttaagccgttttcaggtcgc 
oJL0367 tttagttttaaaacaccagaacttagtttcgacggatatggaaatgacatcagcgtttac 
oJL0368 gagggcgtgaatgtaagcgtgacataactaattacatgatttattgcaggtcagttgcag 
oJL0369 ttagttttaaaacaccagaacttagtttcgacggatatgtctgagagattgctgttcaag 
oJL0370 agggcgtgaatgtaagcgtgacataactaattacatgatttagttgtctaagactacgac 
oJL0371 tagttttaaaacaccagaacttagtttcgacggatatggggaaagatttgagttttaatg 
oJL0372  gtgaatgtaagcgtgacataactaattacatgatttaattatctagaacaatctttttag 
oJL0373 ttttttagttttaaaacaccagaacttagtttcgacggatatgtcgtcttcaaatctatc 
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oJL0374 agggcgtgaatgtaagcgtgacataactaattacatgatttaattatctaaaacaacttg 
oJL0375  ttttagttttaaaacaccagaacttagtttcgacggatatgagtgaattatcatttaaag 
oJL0376 gagggcgtgaatgtaagcgtgacataactaattacatgatttagtccaaaacaatgacac 
oJL0377 ttttttagttttaaaacaccagaacttagtttcgacggatatgagctcacaacaattatc 
oJL0378 gtgaatgtaagcgtgacataactaattacatgatttaattttctaagacaattttatttc 
oJL0379  tttttagttttaaaacaccagaacttagtttcgacggatatgtcgttagaatttaaggac 
oJL0380 gagggcgtgaatgtaagcgtgacataactaattacatgatttagtccaatacgatcttac 
oJL0381 gttttaaaacaccagaacttagtttcgacggatatgacagatactgatttgttatttaag 
oJL0382 gagggcgtgaatgtaagcgtgacataactaattacatgatttaattgtccaaaaccacag 
oJL0383 ttttttagttttaaaacaccagaacttagtttcgacggatatgggtgacaacaagctgag 
oJL0384 gggcgtgaatgtaagcgtgacataactaattacatgatttaattatcaaggacgacatag 
oJL0385 ttttagttttaaaacaccagaacttagtttcgacggatatgtcaggattatccttcaaag 
oJL0386 gagggcgtgaatgtaagcgtgacataactaattacatgatttaattatccaatacaacag 
oJL0387 tttttagttttaaaacaccagaacttagtttcgacggatatgtcgctaactttcaacgac 
oJL0388 gcgtgaatgtaagcgtgacataactaattacatgatttagttggtcaacacaggcatatc 
oJL0389 tttttagttttaaaacaccagaacttagtttcgacggatatgtcccaattaagatttgac 
oJL0390 agggcgtgaatgtaagcgtgacataactaattacatgatttagttactaatgaccacgac 
oJL0391 ttttagttttaaaacaccagaacttagtttcgacggatatgagtgaaatatcattcaaag 
oJL0392 gagggcgtgaatgtaagcgtgacataactaattacatgatttaattattgatggccaatg 
oJL0393  ttttagttttaaaacaccagaacttagtttcgacggatatgggtgagatagagctaaaag 
oJL0394 gggcgtgaatgtaagcgtgacataactaattacatgatttaacggtcaatcaccaaacag 
oJL0395 ttttagttttaaaacaccagaacttagtttcgacggatatgtcagaaatatcatttaaag 
oJL0396 gggcgtgaatgtaagcgtgacataactaattacatgatttagttgttaattgcaatagtc 
oJL0397  ttttagttttaaaacaccagaacttagtttcgacggatatgtcacaattggattttaaag 
oJL0398 gagggcgtgaatgtaagcgtgacataactaattacatgatttaattgttaatagcaatag 
oJL0399 ttttttagttttaaaacaccagaacttagtttcgacggatatggatgtactgcagaatag 
oJL0400 gagggcgtgaatgtaagcgtgacataactaattacatgatttagttgttgattgcaatag 
oJL0401 ttttagttttaaaacaccagaacttagtttcgacggatatgtctccaatagatttcaaag 
oJL0402 gagggcgtgaatgtaagcgtgacataactaattacatgatttaattgttaatagcaatag 
oJL0403 ttttagttttaaaacaccagaacttagtttcgacggatatgtctccagttgattttaaag 
oJL0404 gagggcgtgaatgtaagcgtgacataactaattacatgatttagttgttaatggcaatag 
oJL0405 ttttagttttaaaacaccagaacttagtttcgacggatatgtctctattatcctttaaag 
oJL0406 gagggcgtgaatgtaagcgtgacataactaattacatgatttagttgttgatagcgatgg 
oJL0407 ttttagttttaaaacaccagaacttagtttcgacggatatggccccaataagtttcaaag 
oJL0408 gagggcgtgaatgtaagcgtgacataactaattacatgatttaattgttaatagcaatcg 
oJL0409 ttttagttttaaaacaccagaacttagtttcgacggatatgtcggaaatatctttcaaag 
oJL0410  gagggcgtgaatgtaagcgtgacataactaattacatgatttaattgttgatggcaatgg 
oJL0411 ttttttagttttaaaacaccagaacttagtttcgacggatatgaaaaaggtagacaacgg Clone KR 
homologues from 
Yarrowia lipolytica 
into Helper2 
oJL0412 gagggcgtgaatgtaagcgtgacataactaattacatgattcacatgtatgtcccctttg 
oJL0413 ttttttagttttaaaacaccagaacttagtttcgacggatatgaagaaggtcgactctctctc 
oJL0414 gagggcgtgaatgtaagcgtgacataactaattacatgatttagtagtcatagaagccc 
oJL0415 ttttttagttttaaaacaccagaacttagtttcgacggatatggaaaccaagttgaatgg 
oJL0416 gagggcgtgaatgtaagcgtgacataactaattacatgatctataccgcagacaagccc 
oJL0417  ttttttagttttaaaacaccagaacttagtttcgacggatatgtctggagaactaagatac 
oJL0418 ctcccttggaaacaatctcgtcgacgacaacatcggcaactcgcttgccactgccagcc 
oJL0419 cttcaagggcgacggtgcccaggctggcagtggcaagcgagttgccgatgttgtcgtcgac 
oJL0420 gagggcgtgaatgtaagcgtgacataactaattacatgatttaattgctgatggcggtag 
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oJL0425 aaggaagtaattatctactttttacaacaaatataaaacaatgcctctcgattactccgc Clone HTD 
homologues from 
Yarrowia lipolytica 
into Helper6 
oJL0426 aattagagcgtgatcatgaattaataaaagtgttcgcaaatcacaacttctcgtaagtag 
oJL0427 aaggaagtaattatctactttttacaacaaatataaaacaatgctccgaaccatccgatc 
oJL0428 aattagagcgtgatcatgaattaataaaagtgttcgcaaattactcgttcttgaagttgg 
oJL0429 aaggaagtaattatctactttttacaacaaatataaaacaatgtcacagaccacggcggc 
oJL0430 aattagagcgtgatcatgaattaataaaagtgttcgcaaactagttaacccagtcaagaac 
oJL0431 aaggaagtaattatctactttttacaacaaatataaaacaatgtctttgctgcagaccttcc 
oJL0432 aattagagcgtgatcatgaattaataaaagtgttcgcaaactaaagcttggccttgatctc 
oJL0433 aaggaagtaattatctactttttacaacaaatataaaacaatgggagagacgttcactctg 
oJL0434 aattagagcgtgatcatgaattaataaaagtgttcgcaaattatcgacccttgaaaatgg 
oJL0435 aaggaagtaattatctactttttacaacaaatataaaacaatgcctgccgaacgaacactc 
oJL0436 aattagagcgtgatcatgaattaataaaagtgttcgcaaattactggtggtctctagcag 
oJL0261 tcataacaccaagcaactaatactataacatacaataata atgtcgtcctcagctcatca Clone TER 
homologues into 
Helper3 
oJL0262 aaagaaaaaaattgatctatcgatttcaattcaattcaatttaccattctaaaacaacca 
oJL0263 tcataacaccaagcaactaatactataacatacaataata atgaaatgtactataccaga 
oJL0264 aaagaaaaaaattgatctatcgatttcaattcaattcaatctattgtggtatttcaagaa 
oJL0265 tcataacaccaagcaactaatactataacatacaataata atgaatacagcaaacacttt 
oJL0266 gaaaaaaattgatctatcgatttcaattcaattcaatttaatacaactcatgtccaaaat 
oJL0267 tcataacaccaagcaactaatactataacatacaataata atgtccgcctcgattccaga 
oJL0268 aaagaaaaaaattgatctatcgatttcaattcaattcaatttatttcaagacggcaacca 
oJL0269 tcataacaccaagcaactaatactataacatacaataata atgcaagttgcaattccaga 
oJL0270 aaagaaaaaaattgatctatcgatttcaattcaattcaatctagtttaatacggcaacga 
oJL0271 tcataacaccaagcaactaatactataacatacaataata atgaaggctgtcgtcattga 
oJL0272 aaagaaaaaaattgatctatcgatttcaattcaattcaatctagtttaatacggcaacta 
oJL0273 tcataacaccaagcaactaatactataacatacaataata atggatttttctttaactga 
oJL0274 aaagaaaaaaattgatctatcgatttcaattcaattcaatttatttgttctgatagtctt 
oJL0275 tcataacaccaagcaactaatactataacatacaataataatgggttttctttccggtaa 
oJL0276 aaagaaaaaaattgatctatcgatttcaattcaattcaatttatttcagttcgagttcgt  
oJL0277 tcataacaccaagcaactaatactataacatacaataata atggccatgttcaccactac 
oJL0278 aaagaaaaaaattgatctatcgatttcaattcaattcaatttactgctgagctgcgctcg 
oJL0279 taacaccaagcaactaatactataacatacaataataatgattgtaaaaccaatggttag 
oJL0280 aagaaaaaaattgatctatcgatttcaattcaattcaatttaaatcctgtcgaacctttc 
oJL0305 ttaaatctataactacaaaaaacacatacataaactaaaa atgaatcaacaggatattga Clone EcEutE into 
Helper4 oJL0306 aaagaaaagaagataatatttttatataattatattaatcttaaacaatgcgaaacgcat 
oJL0557 aaagaaagcatagcaatctaatctaagttttaattacaaaatggttgatttcgaatattc Clone CaBdhB into 
Helper5 oJL0558 aaaagatatgcaactagaaaagtcttatcaatctccttacacagattttttgaatatttg 
oJL0537 catcaagaacaaacaagctcaacttgtc Sequencing primers 
for genes cloned 
into Helper 
plasmids 
oJL0538 caagatatcattaaaaatataaaattag 
oJL0539  catatttcttgtcatattcctttctc 
oJL0540 cttttcgtaaatttctggcaaggtag 
oJL0541 cttaacttgtttattattctctcttgtttc 
oJL0542 cttcaggttgtctaactccttccttttc 
oJL0543 gtatcttttcttcccttgtctcaatc 
oJL0544 ctattattttagcgtaaaggatgggg 
oJL0545 catttactattttcccttcttacg 
oJL0546 caatataaaaaagctttccgtagtcatc 
oJL0547 gtttcatttttcttgttctattacaac 
oJL0548 ccagactatatataaggataaattac 
oJL0549 ggtaggtattgattgtaattctgtaaatc 
oJL0550 ctaattcgtagtttttcaagttcttagatgc 
oJL0551 cctttcttaattctgttgtaattaccttcc 
 
